Role of Microvascular Insulin Resistance and Cardiorespiratory Fitness Diabetes
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 150
- 试验地点
- 2
- 主要终点
- Change in insulin sensitivity
研究概览
简要总结
The goal of this two-site grant proposal is to determine the role of the decreased insulin-mediated muscle perfusion found in type 2 diabetes in contributing to the development of cardiac and skeletal muscle dysfunction and subsequent functional exercise impairment. In addition, it is also our goal to determine whether exercise training attenuates insulin resistance and restores insulin-mediated perfusion to the heart and to skeletal muscle, leading to improved cardiac function and exercise performance.
详细描述
It is our goal to determine whether exercise training attenuates insulin resistance and restores insulin-mediated perfusion to the heart and to skeletal muscle, leading to improved cardiac function and exercise performance. Data from our two research teams suggest that the cardiac and skeletal muscle microvascular dysfunction present in people with type 2 diabetes contributes to limitations in cardiac and skeletal muscle function associated with impaired functional exercise capacity (a major predictor of CV and all-cause mortality). Insulin action is a potent predictor of the functional exercise capacity impairment in type 2 diabetes. The exact relationship between insulin action, cardiac and muscle dysfunction, cardiac and skeletal muscle perfusion and decreased functional exercise capacity in type 2 diabetes remains unclear.
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 30 Years 至 55 Years(Adult)
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Sedentary (defined as less than 1 hour per week of physical activity)
- •BMI: 25-40
- •Men and women with and without type 2 diabetes
排除标准
- •Documented cardiovascular disease
- •Uncontrolled hypertension: disease systolic blood pressure (SBP) > 150, diastolic blood pressure (DBP)> 110
- •Obstructive pulmonary disease or asthma
- •Peripheral neuropathy
- •Physical impairment that would limit exercise ability
- •Subjects taking beta blockers, calcium channel blockers, insulin, or Thiazolidinediones (TZD)
- •Current or past smoking within the last 1 years
- •Current tobacco use
- •Control HbA1c > 5.7, T2DM HbA1c > 9
- •Pregnant, nursing or hormonal therapy (other than contraceptives)
- •Peri or post-menopausal women
- •Type 1 diabetes
- •Hepatic or renal disease.
研究组 & 干预措施
Type 2 Diabetes
Participants aged 30-55 with type 2 diabetes
干预措施: Cardiovascular exercise (Behavioral)
Healthy overweight control
Participants aged 30-55 with BMI 25-40 without type 2 diabetes
干预措施: Cardiovascular exercise (Behavioral)
结局指标
主要结局
Change in insulin sensitivity
时间窗: Through study completion, approximately 4 months
The investigators will evaluate the changes in insulin sensitivity utilizing a euglycemic insulin clamp
Change in peak oxygen consumption (VO2)
时间窗: Through study completion, approximately 4 months
Subjects' peak oxygen consumption will be tested on a stationary bike before and after 15 weeks of exercise
次要结局
未报告次要终点
